SB202190 is a selective and specific p38 MAPK inhibitor. It affects the p38 MAPK signaling pathway, and by blocking p38 phosphorylation and activation, it effectively inhibits apoptosis, inflammation, and tumor metastasis, while promoting stem cell survival.
SB202190 IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for SB202190 Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.